Laser photocoagulation remains the first-line treatment for diabetic macular edema (DME) in most patients globally despite the availability of intravitreal steroids and inhibitors of vascular endothelial growth factor (VEGF). This evidence concerns the gene VEGFA and diabetic macular edema.